Wells Pharmacy Network (WPN) is excited to announce the addition of FIVE new medicines to our expanding product portfolio!
Included in these new medications are:
- ● Testofensine – capsules
- ● Semaglutide + BPC 157 (Oral) – capsules
- ● Semaglutide + BPC 157 (Injectable)
- ● KPV
- ● KPV + BPC 157
Our anti-obesity formulations Tesofensine (TE), Semaglutide + BPC-157 9 (oral) and Semaglutide + BPC-157 (injectable), which has been labeled a weight loss “game changer,” by medical researchers. Rounding out the new products are peptides KPV and KPV + BPC-157. KVP is a peptide produced naturally in the body that effectively treats inflammation, gut health, and conditions such as Inflammatory Bowel Disease (IBD) and colon cancer. BPC-157 triggers the formation of new blood vessels (angiogenesis), and in conjunction with KPV, can provide many additional benefits including treating intestinal inflammation, healing stomach ulcers, improving wound healing, and boosting bone/joint healing.
WPN is proud to bring these new innovative products to our patient and physician customers! If you have any questions about these new medications, visit www.wellsrx.com, or call (866) 506-2174 to speak to a product expert!
